Maxim Group


Maxim Analysts Bullish On Pioneering Biotech Stocks: Mast Therapeutics Inc (MSTX) and StemCells Inc (STEM)

Both Mast Therapeutics Inc (NYSEMKT:MSTX) and StemCells Inc (NASDAQ:STEM) are in deep waters where few other biotech giants tread. While Mast is working …

Analysts Speculate on Two Biotech Stocks: Anavex Life Sciences Corp. (AVXL) and Cytosorbents Corp (CTSO)

Optimistic views on Alzheimer remedy in its making by Anavex Life Sciences Corp (NYSE:AVXL) and improved earnings report by Cytosorbents Corp (NASDAQ:CTSO) caused analysts …

Analysts Weigh In on Biotech Stocks Following Pipeline Updates and Earnings: AEterna Zentaris Inc. (AEZS) and Horizon Pharma PLC (HZNP)

Biotechnology stocks AEterna Zentaris Inc. (NASDAQ:AEZS) and Horizon Pharma PLC (NASDAQ:HZNP) take the center stage after analysts provide a pipeline update on a drug …

Healthcare Analysts Bullish on Allergan plc Ordinary Shares (AGN) and Cytori Therapeutics Inc (CYTX) Following Earnings and Data Release

Healthcare analysts from Mizuho and Maxim weigh in on pharma giant Allergan plc Ordinary Shares (NYSE:AGN) and cell therapy firm Cytori Therapeutics Inc (NASDAQ:CYTX), following …

Analysts Bullish on Small-Cap Biotech Stocks: Cytokinetics, Inc. (CYTK) and Anavex Life Sciences Corp. (AVXL)

Many investors hope to win big on biotech stocks as shares can sky rocket when there is good news. Analysts explain why there are plenty …

Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 3Q Update

In a research report published Friday, Maxim Group analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with …

Maxim Weighs In On AEterna Zentaris Inc. (USA) (AEZS) As The DSMB Recommends ZoptEC Phase 3 To Continue

Maxim Group analyst Jason Kolbert came out today with a few insights on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS), after the company announced that the independent Data and Safety …

Maxim Pounds the Table on Kite Pharma Inc (KITE)

Maxim analyst Jason McCarthy was out pounding the table on Kite Pharma Inc (NASDAQ:KITE) Thursday, reiterating a Buy rating and a price target of $87, which implies …

Maxim Reiterates Upbeat View of TrovaGene Inc Following Positive HPV HR Test Data

Maxim’s healthcare analyst Jason Kolbert came out with a positive commentary on TrovaGene Inc (NASDAQ:TROV), following the news that the company’s urine-based HPV HR Test is equally capable of detecting …

Maxim Weighs In on Inovio Pharmaceuticals Inc Following $24 Million Grant Option From DARPA

Maxim analyst Jason McCarthy came out with a brief commentary on Inovio Pharmaceuticals Inc (NASDAQ:INO), after the company announced yesterday that the US Defense Advanced Research Projects Agency (DARPA) has …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts